<?xml version="1.0" encoding="UTF-8"?>
<p id="p0120"> CP treatments have been often focused on 
 <bold>enteric viruses</bold> such as norovirus, adenovirus, and hepatitis A virus. These are the leading causes of 
 <bold>acute gastroenteritis</bold>, the second most common infectious disease worldwide, which is responsible for high levels of hospitalization and mortality [
 <xref rid="bb0090" ref-type="bibr">18</xref>]. Working with human viruses can pose serious health hazards, and such studies require specialized laboratories and equipment. Moreover, infectivity assessments of important enteric viruses, such as norovirus, have been limited owing to a lack of cultivation methods [
 <xref rid="bb0095" ref-type="bibr">19</xref>]. For these reasons, these viruses are often replaced by surrogate viruses.
</p>
